Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 1 |
2018 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Enhancing venetoclax activity in hematological malignancies.
Expert Opin Investig Drugs. 2020 Jul;29(7):697-708. doi: 10.1080/13543784.2020.1789588. Epub 2020 Jul 16.
Expert Opin Investig Drugs. 2020.
PMID: 32600066
Free PMC article.
Review.
Clinical experience of CAR T cells for multiple myeloma.
Simmons GL, Satta T, Castaneda Puglianini O.
Simmons GL, et al. Among authors: satta t.
Best Pract Res Clin Haematol. 2021 Sep;34(3):101306. doi: 10.1016/j.beha.2021.101306. Epub 2021 Aug 28.
Best Pract Res Clin Haematol. 2021.
PMID: 34625232
Review.
Item in Clipboard
Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax.
Satta T, Li L, Chalasani SL, Hu X, Nkwocha J, Sharma K, Kmieciak M, Rahmani M, Zhou L, Grant S.
Satta T, et al.
Clin Cancer Res. 2023 Apr 3;29(7):1332-1343. doi: 10.1158/1078-0432.CCR-22-2729.
Clin Cancer Res. 2023.
PMID: 36652560
Free PMC article.
Item in Clipboard
Mechanisms underlying synergism between circularized tumor necrosis factor-related apoptosis inducing ligand and bortezomib in bortezomib-sensitive or -resistant myeloma cells.
Leng Y, Hu X, Li L, Nkwocha J, Satta T, Sharma K, Kmeiciak M, Zhou H, Zhang Z, Zhou L, Chen W, Grant S.
Leng Y, et al. Among authors: satta t.
Hematol Oncol. 2022 Dec;40(5):999-1008. doi: 10.1002/hon.3045. Epub 2022 Jul 14.
Hematol Oncol. 2022.
PMID: 35789025
Free PMC article.
Item in Clipboard
Blood Transfusion Management and Transfusion-Related Outcomes in Daratumumab-Treated Patients With Relapsed or Refractory Multiple Myeloma.
Chari A, Arinsburg S, Jagannath S, Satta T, Treadwell I, Catamero D, Morgan G, Feng H, Uhlar C, Khan I, Doshi P, Usmani S.
Chari A, et al. Among authors: satta t.
Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):44-51. doi: 10.1016/j.clml.2017.09.002. Epub 2017 Sep 19.
Clin Lymphoma Myeloma Leuk. 2018.
PMID: 29054515
Free article.
Item in Clipboard
Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia - a propensity score analysis.
Sasaki K, Kantarjian H, Jabbour E, Ravandi F, Takahashi K, Konopleva M, Borthakur G, Garcia-Manero G, Wierda W, Daver N, Jain P, Satta T, Pierce S, Rios MB, Cortes JE.
Sasaki K, et al. Among authors: satta t.
Haematologica. 2016 Aug;101(8):e324-7. doi: 10.3324/haematol.2015.139089. Epub 2016 May 12.
Haematologica. 2016.
PMID: 27175025
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite